Ira Kalfus
30+ years in medicine and 15+ years in drug development, with a track record including FDA approvals and successful acquisitions.
Sid Labed
Sid Labed is a serial biotech founder and Harvard Medical School alum
Anas Fathallah
former Biogen Senior Translational/Clinical Pharmacologist Leader, overseeing preclinical development at EvoDenovo.
Brock Grill
Dr. Brock Grill is a Professor at the Department of Pediatrics, University of Washington; his lab laid the foundation for the GPR139 anti opioid program.
Jeff Leighton
Drug Development advisor
Fred Ausubel
Harvard Medical School Professor of Genetics and MGH Distinguished Investigator
Javier Irazoqui
Scientific Advisory Board Member
Kirill Martemyanov
Professor and Chair at the University of Miami Miller School of Medicine; his lab laid the groundwork for the GPR158/mGlyR pathway in stress-induced depression.